ERα Degrader-2 is a selective estrogen receptor degrader (SERD) with potent binding affinity to ERα (IC50 = 17.1 nM) and effective degradation activity (EC50 = 0.3 nM); it exhibits favorable pharmacokinetic properties and drug-like characteristics, and is used in the research of HER-positive breast cancer.